Literature DB >> 12528816

Characterization of an O-glycosylated plaque-associated protein from Alzheimer disease brain.

Blanca Espinosa1, Jorge Guevara, Pedro Hernández, Marie-Christine Slomianny, Aida Guzmán, Salvador Martínez-Cairo, Edgar Zenteno.   

Abstract

In this work we characterized a 90-kDa glycoprotein from Alzheimer disease (9OAzgp) brain extracts that is recognized by the GalNAc-specific lectin from Amaranthus leucocarpus (ALL), as determined through Western blot. The 90Azgp was purified by electro-elution, and its amino acid sequence determined from peptides obtained after trypsin digestion through MALDI-TOF (Matrix-assisted laser desorption ionization-time of flight), and compared with the relative values obtained from the NCBInr (Swiss-Prot 10/01/2001) database. The 90Azgp showed 32% and 42% homology with the KIAA0310 protein from human brain and the human gastric mucin, respectively. Presence of O-glycosidically linked glycans in the proteins recognized by ALL was confirmed by inhibition of the lectin-glycoprotein interaction through hapten-inhibition assays and also by elimination of the O-glycosidically linked glycans after treatment with O-glycanase from Diplococcus pneumoniae. Electron transmission microscopy confirmed that the receptor recognized by the lectin is processed in the Golgi apparatus of AD neurons. Although the specific role of this glycoprotein has not been identified, considering that the presence of this lectin receptor co-localized with neuritic plaques and in AD sprouting neurons, it could suggest that the O-glycosyl-protein identified by the A. leucocarpus lectin participates in the pathogenesis of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12528816     DOI: 10.1093/jnen/62.1.34

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  5 in total

1.  Prediction of mucin-type O-glycosylation sites by a two-staged strategy.

Authors:  YuDong Cai; JianFeng He; Lin Lu
Journal:  Mol Divers       Date:  2010-07-22       Impact factor: 2.943

Review 2.  Neuroinflammation and galectins: a key relationship in neurodegenerative diseases.

Authors:  Eleazar Ramírez Hernández; Beatriz Alanis Olvera; Daniela Carmona González; Oscar Guerrero Marín; Denisse Pantoja Mercado; Lucero Valencia Gil; Luis F Hernández-Zimbrón; José Luis Sánchez Salgado; I Daniel Limón; Edgar Zenteno
Journal:  Glycoconj J       Date:  2022-06-02       Impact factor: 3.009

3.  Proteomic profiling of phosphoproteins and glycoproteins responsive to wild-type alpha-synuclein accumulation and aggregation.

Authors:  Jayanarayan Kulathingal; Li-Wen Ko; Bernadette Cusack; Shu-Hui Yen
Journal:  Biochim Biophys Acta       Date:  2008-10-22

4.  Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.

Authors:  Gary W Beecham; Kara Hamilton; Adam C Naj; Eden R Martin; Matt Huentelman; Amanda J Myers; Jason J Corneveaux; John Hardy; Jean-Paul Vonsattel; Steven G Younkin; David A Bennett; Philip L De Jager; Eric B Larson; Paul K Crane; M Ilyas Kamboh; Julia K Kofler; Deborah C Mash; Linda Duque; John R Gilbert; Harry Gwirtsman; Joseph D Buxbaum; Patricia Kramer; Dennis W Dickson; Lindsay A Farrer; Matthew P Frosch; Bernardino Ghetti; Jonathan L Haines; Bradley T Hyman; Walter A Kukull; Richard P Mayeux; Margaret A Pericak-Vance; Julie A Schneider; John Q Trojanowski; Eric M Reiman; Gerard D Schellenberg; Thomas J Montine
Journal:  PLoS Genet       Date:  2014-09-04       Impact factor: 5.917

Review 5.  Early Stage Glycosylation Biomarkers in Alzheimer's Disease.

Authors:  Patricia Regan; Paula L McClean; Thomas Smyth; Margaret Doherty
Journal:  Medicines (Basel)       Date:  2019-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.